カテゴリー： 世界, 医療/バイオ, FactMR

世界の基底細胞がん市場2023-2033：治療タイプ別（手術、薬物、放射線治療）、エンドユーザー別（病院、専門クリニック）、地域別

【英語タイトル】Basal Cell Carcinoma Treatment Market Analysis By Treatment Type (Surgery, Drugs, Radiation Therapy), By End User (Hospitals, Specialty Clinics) & Region – Global Market Insights 2023 to 2033

FactMRが出版した調査資料（FACT23AP083）・商品コード：FACT23AP083
・発行会社（調査会社）：FactMR
・発行日：2023年1月17日
・ページ数：約170
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Site License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Fact.MR社発行の最新調査レポートでは、世界の基底細胞がん市場について2023年から2033年までの市場動向を分析・予測しています。当レポートは、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、治療タイプ別（手術、薬物、その他）分析、エンドユーザー別（病院、専門クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析など、多面的な分析結果をまとめたものです。なお、企業情報として、Sun Pharmaceuticals Ltd.、Valeant Pharmaceuticals International, Inc.、Mylan N.V.などが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場動向
・世界の基底細胞がん市場規模：治療タイプ別
　- 手術の市場規模
　- 薬物治療の市場規模
　- その他治療タイプの市場規模
・世界の基底細胞がん市場規模：エンドユーザー別
　- 病院における市場規模
　- 専門クリニックにおける市場規模
　- その他エンドユーザーにおける市場規模
・世界の基底細胞がん市場規模：地域別
　- 北米の基底細胞がん市場規模
　- ヨーロッパの基底細胞がん市場規模
　- アジア太平洋の基底細胞がん市場規模
　- 中南米の基底細胞がん市場規模
　- 中東/アフリカの基底細胞がん市場規模
・企業情報

本レポートには、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。また、購読者に実用的な洞察を提供し、熟考して市場の状況を示し、基底細胞がんにおける競争レベルを推測するのに役立ちます。

Basal Cell Carcinoma Treatment Market – Scope of Report

A recent study by Fact.MR on the basal cell carcinoma treatment market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering basal cell carcinoma treatment.

The study also provides the dynamics responsible for influencing the future status of the basal cell carcinoma treatment market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the basal cell carcinoma treatment market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of basal cell carcinoma treatment across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of basal cell carcinoma treatment during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for basal cell carcinoma treatment are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global basal cell carcinoma treatment market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the basal cell carcinoma treatment market during the forecast period.

Country-specific valuation on demand for basal cell carcinoma treatment has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of basal cell carcinoma treatment, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering basal cell carcinoma treatment has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the basal cell carcinoma treatment domain.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Basal Cell Carcinoma Treatment: Market Snapshot

    3.2. Market Share Analysis by Region, 2016

    3.3. Market Opportunity Map

4. Market Overview

    4.1. Market Overview

    4.2. Global Market: Market Indicators

    4.3. Global Market Size (US$ Mn) Forecast, 2023 to 2033

    4.4. Global Market: Market Outlook

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

        5.2.1. Changing Environmental Factors

        5.2.2. Stringent Regulatory Policies Assuring Better Product Quality

        5.2.3. Favorable Reimbursement Scenario

        5.2.4. Growing Disease Awareness Initiatives

        5.2.5. Rise in Geriatric Population

    5.3. Restraints

        5.3.1. Lack of Awareness in Developing Countries

        5.3.2. High Cost of Treatment

    5.4. Opportunities

        5.4.1. Emerging Markets in Developing Countries

        5.4.2. Alternative Potential Therapies

    5.5. Key Trends

    5.6. Market: Value Chain Analysis

    5.7. Pipeline Analysis: Basal Cell Carcinoma Market

    5.8. Key Success Factors of Top 3 Companies

    5.9. Healthcare Overview

6. Market Analysis, by Treatment

    6.1. Introduction

    6.2. Global Market Value Share Analysis, by Treatment

    6.3. Market Forecast, by Treatment

        6.3.1. Surgical

            6.3.1.1. Surgical Excision

            6.3.1.2. Electrodessication & Cutterage (ED&C)

            6.3.1.3. Moh’s Surgery

            6.3.1.4. Cryosurgery

        6.3.2. Drugs

            6.3.2.1. Topical Treatment

            6.3.2.2. Advanced Medication

            6.3.2.3. Other

        6.3.3. Others

            6.3.3.1. Radiation Therapy

            6.3.3.2. Photodynamic Therapy (PDT)

            6.3.3.3. Laser Therapy

    6.4. Market Attractiveness Analysis, by Treatment

7. Market Analysis, by End-user

    7.1. Introduction

    7.2. Global Market Value Share Analysis, by End-user

    7.3. Market Forecast, by End-user

        7.3.1. Hospitals

        7.3.2. Specialty Clinics

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Market Analysis, by Region

    8.1. Global Market, Global Market Scenario

    8.2. Global Market Value Share Analysis, by Region

    8.3. Market Forecast, by Region

    8.4. Market Attractiveness Analysis, by Region

9. North America Market Analysis

    9.1. Regional Outlook

    9.2. Market Overview

    9.3. Market Analysis, by Treatment

        9.3.1. Market Value Share Analysis, by Treatment

        9.3.2. Market Size (US$ Mn) Forecast, by Treatment

            9.3.2.1. Surgical

                9.3.2.1.1. Surgical Excision

                9.3.2.1.2. Electrodessication & Cutterage (ED&C)

                9.3.2.1.3. Moh’s Surgery

                9.3.2.1.4. Cryosurgery

            9.3.2.2. Drugs

                9.3.2.2.1. Topical Treatment

                9.3.2.2.2. Advanced Medication

                9.3.2.2.3. Other

            9.3.2.3. Others

                9.3.2.3.1. Radiation Therapy

                9.3.2.3.2. Photodynamic Therapy (PDT)

                9.3.2.3.3. Laser Therapy

    9.4. Market Analysis, by End-user

        9.4.1. Market Value Share Analysis, by End-user

        9.4.2. Market Size (US$ Mn) Forecast, by End-user

            9.4.2.1. Hospitals

            9.4.2.2. Specialty Clinics

            9.4.2.3. Others

    9.5. Market Analysis, by Country

        9.5.1. Market Value Share Analysis, by Country

        9.5.2. Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

            9.5.2.1. U.S.

            9.5.2.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. by Country

        9.6.2. by Treatment

        9.6.3. by End-user

10. Europe Market Analysis

    10.1. Regional Outlook

    10.2. Market Overview

    10.3. Market Analysis, by Treatment

        10.3.1. Market Value Share Analysis, by Treatment

        10.3.2. Market Size (US$ Mn) Forecast, by Treatment

            10.3.2.1. Surgical

                10.3.2.1.1. Surgical Excision

                10.3.2.1.2. Electrodessication & Cutterage (ED&C)

                10.3.2.1.3. Moh’s Surgery

                10.3.2.1.4. Cryosurgery

            10.3.2.2. Drugs

                10.3.2.2.1. Topical Treatment

                10.3.2.2.2. Advanced Medication

                10.3.2.2.3. Other

            10.3.2.3. Others

                10.3.2.3.1. Radiation Therapy

                10.3.2.3.2. Photodynamic Therapy (PDT)

                10.3.2.3.3. Laser Therapy

    10.4. Market Analysis, by End-user

        10.4.1. Market Value Share Analysis, by End-user

        10.4.2. Market Size (US$ Mn) Forecast, by End-user

            10.4.2.1. Hospitals

            10.4.2.2. Specialty Clinics

            10.4.2.3. Others

    10.5. Market Analysis, by Country

        10.5.1. Market Value Share Analysis, by Country

        10.5.2. Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

            10.5.2.1. UK

            10.5.2.2. Germany

            10.5.2.3. France

            10.5.2.4. Spain

            10.5.2.5. Italy

            10.5.2.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. by Country

        10.6.2. by Treatment

        10.6.3. by End-user

11. Asia Pacific Market Analysis

    11.1. Regional Outlook

    11.2. Market Overview

    11.3. Market Analysis, by Treatment

        11.3.1. Market Value Share Analysis, by Treatment

        11.3.2. Market Size (US$ Mn) Forecast, by Treatment

            11.3.2.1. Surgical

                11.3.2.1.1. Surgical Excision

                11.3.2.1.2. Electrodessication & Cutterage (ED&C)

                11.3.2.1.3. Moh’s Surgery

                11.3.2.1.4. Cryosurgery

            11.3.2.2. Drugs

                11.3.2.2.1. Topical Treatment

                11.3.2.2.2. Advanced Medication

                11.3.2.2.3. Other

            11.3.2.3. Others

                11.3.2.3.1. Radiation Therapy

                11.3.2.3.2. Photodynamic Therapy (PDT)

                11.3.2.3.3. Laser Therapy

    11.4. Market Analysis, by End-user

        11.4.1. Market Value Share Analysis, by End-user

        11.4.2. Market Size (US$ Mn) Forecast, by End-user

            11.4.2.1. Hospitals

            11.4.2.2. Specialty Clinics

            11.4.2.3. Others

    11.5. Market Analysis, by Country

        11.5.1. Market Value Share Analysis, by Country

        11.5.2. Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

            11.5.2.1. Australia & New Zealand

            11.5.2.2. Japan

            11.5.2.3. China

            11.5.2.4. Rest of APAC

    11.6. Market Attractiveness Analysis

        11.6.1. by Country

        11.6.2. by Treatment

        11.6.3. by End-user

12. Latin America Market Analysis

    12.1. Regional Outlook

    12.2. Market Overview

    12.3. Market Analysis, by Treatment

        12.3.1. Market Value Share Analysis, by Treatment

        12.3.2. Market Size (US$ Mn) Forecast, by Treatment

            12.3.2.1. Surgical

                12.3.2.1.1. Surgical Excision

                12.3.2.1.2. Electrodessication & Cutterage (ED&C)

                12.3.2.1.3. Moh’s Surgery

                12.3.2.1.4. Cryosurgery

            12.3.2.2. Drugs

                12.3.2.2.1. Topical Treatment

                12.3.2.2.2. Advanced Medication

                12.3.2.2.3. Other

            12.3.2.3. Others

                12.3.2.3.1. Radiation Therapy

                12.3.2.3.2. Photodynamic Therapy (PDT)

                12.3.2.3.3. Laser Therapy

    12.4. Market Analysis, by End-user

        12.4.1. Market Value Share Analysis, by End-user

        12.4.2. Market Size (US$ Mn) Forecast, by End-user

            12.4.2.1. Hospitals

            12.4.2.2. Specialty Clinics

            12.4.2.3. Others

    12.5. Market Analysis, by Country

        12.5.1. Market Value Share Analysis, by Country

        12.5.2. Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

            12.5.2.1. Brazil

            12.5.2.2. Mexico

            12.5.2.3. Rest of LATAM

    12.6. Market Attractiveness Analysis

        12.6.1. by Country

        12.6.2. by Treatment

        12.6.3. by End-user

13. Middle East & Africa Market Analysis

    13.1. Regional Outlook

    13.2. Market Overview

    13.3. Market Analysis, by Treatment

        13.3.1. Market Value Share Analysis, by Treatment

        13.3.2. Market Size (US$ Mn) Forecast, by Treatment

            13.3.2.1. Surgical

                13.3.2.1.1. Surgical Excision

                13.3.2.1.2. Electrodessication & Cutterage (ED&C)

                13.3.2.1.3. Moh’s Surgery

                13.3.2.1.4. Cryosurgery

            13.3.2.2. Drugs

                13.3.2.2.1. Topical Treatment

                13.3.2.2.2. Advanced Medication

                13.3.2.2.3. Other

            13.3.2.3. Others

                13.3.2.3.1. Radiation Therapy

                13.3.2.3.2. Photodynamic Therapy (PDT)

                13.3.2.3.3. Laser Therapy

    13.4. Market Analysis, by End-user

        13.4.1. Market Value Share Analysis, by End-user

        13.4.2. Market Size (US$ Mn) Forecast, by End-user

            13.4.2.1. Hospitals

            13.4.2.2. Specialty Clinics

            13.4.2.3. Others

    13.5. Market Analysis, by Country

        13.5.1. Market Value Share Analysis, by Country

        13.5.2. Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

            13.5.2.1. South Africa

            13.5.2.2. GCC Countries

            13.5.2.3. Rest of MEA

    13.6. Market Attractiveness Analysis

        13.6.1. by Country

        13.6.2. by Treatment

        13.6.3. by End-user

14. Company Profiles

    14.1. Market Share Analysis, by Company (2016)

    14.2. Company Profiles

        14.2.1. Sun Pharmaceuticals Ltd.

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.1.2. Financial Overview

            14.2.1.3. Product Portfolio

            14.2.1.4. SWOT Analysis

            14.2.1.5. Strategic Overview

        14.2.2. Valeant Pharmaceuticals International, Inc.

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.2.2. Financial Overview

            14.2.2.3. Product Portfolio

            14.2.2.4. SWOT Analysis

            14.2.2.5. Strategic Overview

        14.2.3. Mylan N.V.

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.3.2. Financial Overview

            14.2.3.3. Product Portfolio

            14.2.3.4. SWOT Analysis

            14.2.3.5. Strategic Overview

        14.2.4. F. Hoffmann-La Roche Ltd.

            14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.4.2. Financial Overview

            14.2.4.3. Product Portfolio

            14.2.4.4. SWOT Analysis

            14.2.4.5. Strategic Overview

        14.2.5. Merck & Co., Inc.

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.5.2. Financial Overview

            14.2.5.3. Product Portfolio

            14.2.5.4. SWOT Analysis

            14.2.5.5. Strategic Overview

Table 01: Global Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033

Table 02: Global Market Size (US$ Mn) Forecast, by Surgical Treatment, 2023 to 2033

Table 03: Global Market Size (US$ Mn) Forecast, by Drugs Treatment, 2023 to 2033

Table 04: Global Market Size (US$ Mn) Forecast, by Other Treatment, 2023 to 2033

Table 05: Global Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 06: Global Market Size (US$ Mn) Forecast, by Region, 2023 to 2033

Table 07: North America Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033

Table 08: North America Market Size (US$ Mn) Forecast, by Surgical Treatment

Table 09: North America Market Size (US$ Mn) Forecast, by Drugs Treatment

Table 10: North America Market Size (US$ Mn) Forecast, by Other Treatment

Table 11: Global Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 12: North America Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 13: Europe Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033

Table 14: Europe Market Size (US$ Mn) Forecast, by Surgical Treatment, 2023 to 2033

Table 15: Europe Market Size (US$ Mn) Forecast, by Drugs Treatment, 2023 to 2033

Table 16: Europe Market Size (US$ Mn) Forecast, by Other Treatment, 2023 to 2033

Table 17: Europe Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 18: Europe Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 19: Asia Pacific Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033

Table 20: Asia Pacific Market Size (US$ Mn) Forecast, by Surgical Treatment

Table 21: Asia Pacific Market Size (US$ Mn) Forecast, by Drugs Treatment, 2023 to 2033

Table 22: Asia Pacific Market Size (US$ Mn) Forecast, by Other Treatment, 2023 to 2033

Table 23: Asia Pacific Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 24: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 25: Latin America Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033

Table 26: Latin America Market Size (US$ Mn) Forecast, by Surgical Treatment

Table 27: Latin America Market Size (US$ Mn) Forecast, by Drugs Treatment

Table 28: Latin America Market Size (US$ Mn) Forecast, by Other Treatment

Table 29: Latin America Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 30: Latin America Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 31: Middle East & Africa Market Size (US$ Mn) Forecast, by Treatment

Table 32: Middle East & Africa Market Size (US$ Mn) Forecast, by Surgical Treatment, 2023 to 2033

Table 33: Middle East & Africa Market Size (US$ Mn) Forecast, by Drugs Treatment, 2023 to 2033

Table 34: Middle East & Africa Market Size (US$ Mn) Forecast, by Other Treatment, 2023 to 2033

Table 35: Middle East & Africa Market Size (US$ Mn) Forecast, by End-user

Table 36: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

★調査レポート[世界の基底細胞がん市場2023-2033：治療タイプ別（手術、薬物、放射線治療）、エンドユーザー別（病院、専門クリニック）、地域別] (コード：FACT23AP083)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の基底細胞がん市場2023-2033：治療タイプ別（手術、薬物、放射線治療）、エンドユーザー別（病院、専門クリニック）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の慢性特発性便秘治療市場2023-2033：種類別（正常通過性便秘、緩徐通過性便秘）、治療法別（薬物療法、非薬物療法）、治療別（投薬、手術）、薬剤別（セロトニン4（5-Ht4）受容体作動薬、グアニル酸シクラーゼCアゴニスト、下剤、興奮剤）、投与経路別（経口、注射）、エンドユーザー別（病院、在宅医療、専門クリニック）、地域別
  • 世界の半盲市場2023-2033：種類別（同名半盲、四分一盲、両側頭半盲）、治療別（視力回復療法、視野拡大補助）、エンドユーザー別（病院、専門クリニック）、地域別
  • 世界の腎臓結石管理デバイス市場2023-2033：製品タイプ別（結石破砕装置、尿管鏡、腎臓鏡）、エンドユーザー別（病院、専門クリニック、外来手術センター）、地域別
  • 世界の心肺負荷試験市場2023-2033：製品別（CPETシステム、ストレスECG、パルスオキシメーター、SPECT、ストレス血圧モニター）、エンドユーザー別（病院、専門クリニック/循環器科クリニック、外来手術センター、診断センター）、地域別
  • 世界の人工腎臓市場2023-2033：種類別（ウェアラブル型人工腎臓、埋め込み型人工腎臓）、透析別（血液透析、腹膜透析、併用療法）、用途別（成人、小児）、エンドユーザー別（病院、専門クリニック、外来手術センター）、地域別
  • 世界の遠心式血液ポンプ市場（2023-2033）：種類別（電子式、機械式）、エンドユーザー別（病院、外来手術センター、専門クリニック、その他）
  • 世界の尿路カテーテル市場2023-2033：製品別（間欠カテーテル、フォーリー/留置カテーテル、外付カテーテル）、種類別（コーティング型カテーテル、非コーティング型カテーテル）、エンドユーザー別（病院、専門クリニック、外来手術センター）、用途別、地域別
  • 世界のゼラチン・骨接着剤市場（2023-2033）：製品別（ゼラチン、骨接着剤）、用途別（人工関節置換術、スポーツ障害、脊椎手術、外傷）、エンドユーザー別（病院、専門クリニック、外来手術センター）、地域別
  • 世界のハイドロサージェリー装置市場2023-2033：コンポーネント別（装置コンソール、ハンドピース、付属品）、用途別（急性創傷、慢性創傷、手術創、外傷、熱傷）、エンドユーザー別（病院、専門クリニック、外来手術センター、長期治療センター、在宅医療装置）、地域別
  • 世界の経鼻薬物送達技術市場（2023-2033)：容器別（加圧容器、非加圧容器）、投与方法別（2回点鼻、複数回点鼻、単回点鼻）、剤形別（点鼻スプレー、点鼻液・液体、点鼻ジェル、点鼻粉末、その他）、用途別（呼吸器疾患、非呼吸器疾患）、エンドユーザー別（在宅医療、病院、専門クリニック、その他）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆